Ablation Technology Market Report 2024

The ablation technology market size has grown strongly in recent years. It will grow from $4.92 billion in 2023 to $5.35 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period can be attributed to several factors, including increased awareness among patients and physicians, rising healthcare expenditure, higher disposable incomes, growing acceptance of radiofrequency ablation (RFA), and improved access to ablation procedures.

The ablation technology market size is expected to see strong growth in the next few years. It will grow to $7.54 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The growth during the forecast period can be attributed to several factors, including the rising prevalence of chronic diseases, increased demand for minimally invasive procedures, an aging population, a higher number of surgical procedures, and government initiatives supporting healthcare infrastructure. Major trends expected during this period include technological advancements in ablation technology, its expanding use in treating various types of tumors, improved access to healthcare, advantages of ablation technology over traditional surgery, and increased collaborations and partnerships within the industry.

The increasing demand for minimally invasive treatments is expected to drive the growth of the ablation technology market. Minimally invasive treatments involve performing medical procedures through small incisions or natural body openings using specialized instruments guided by imaging techniques. These treatments are gaining popularity due to their ability to reduce recovery times, lower surgical risks, and improve patient outcomes compared to traditional surgical methods. Ablation technology plays a crucial role in these procedures by targeting and destroying diseased tissues with high precision while minimizing damage to surrounding healthy tissues. For example, the American Society of Plastic Surgeons reported in January 2023 that the number of minimally invasive cosmetic surgeries in the US increased from approximately 23.7 million in 2022 to around 25.4 million in 2023, reflecting a 7% rise. Consequently, the growing demand for minimally invasive treatments is fueling the expansion of the ablation technology market.

Leading companies in the ablation technology sector are focusing on developing advanced technologies such as thin-film electrode technology to enhance precision and effectiveness in treating cardiac arrhythmias, shorten procedure times, and improve patient outcomes. Thin-film electrode technology involves using ultra-thin conductive layers to create precise electrodes for targeted ablation treatments. For instance, in March 2024, NeuroOne, a US-based medical equipment manufacturer, introduced the OneRF Ablation System. This system employs thin-film, stereo electroencephalography (SEEG)-guided radiofrequency (RF) technology to record electrical activity and perform precise ablation of nervous tissue with temperature controls, using the same electrode for both diagnosis and treatment. The OneRF ablation system is NeuroOne’s first therapeutic device and its third FDA-cleared product, complementing the company’s Evo cortical and sEEG electrode lines, which are used for short-term brain electrical activity recording.

In August 2022, Medtronic plc, a US-based medical device company, acquired Affera Inc. for an undisclosed amount. This acquisition underscores Medtronic's strategic focus on advancing its electrophysiology capabilities and improving the treatment of cardiac arrhythmias with innovative catheter-based technologies. Affera Inc., based in the US, specializes in ablation technology.

Major companies operating in the ablation technology market are Johnson & Johnson, Abbott Laboratories, Medtronic Plc., Siemens Healthineers AG, Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, Olympus America, Terumo Corporation, Smith & Nephew plc, Hologic Inc., Perseon Corporation, Conmed Corporation, Accuray Incorporated, AtriCure Inc., AngioDynamics, Biosense Webster Inc., HealthTronics, Creo Medical Ltd., Misonix, NxThera, MedWaves Inc., Theraclion.

North America was the largest region in the ablation technology market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ablation technology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ablation technology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Ablation technology involves the removal or destruction of tissue using methods such as heat, cold, chemicals, or lasers. It is widely used in medical procedures to address conditions such as tumors, arrhythmias, or chronic pain, providing a minimally invasive approach with precise targeting and reduced damage to surrounding tissues.

The main types of ablation technology products include cryoablation devices, electrical ablators, hydrothermal or hydromechanical ablators, laser or light ablators, microwave ablators, radiofrequency ablators, ultrasound ablators, and others. Cryoablation devices are used in interventional radiology and surgery to destroy tissue through extreme cold. These devices employ various technologies such as thermal and non-thermal ablation techniques. Applications for ablation technology span several medical fields, including cardiovascular disease treatment, cancer therapy, gynecological procedures, cosmetic or aesthetic surgery, pain management, orthopedic treatment, urological care, and ophthalmologic treatment. The end users of these technologies include ambulatory surgical centers, hospitals and ablation centers, medical spas and aesthetic clinics, and other medical facilities.

The ablation technology market research report is one of a series of new reports that provides ablation technology market statistics, including ablation technology industry global market size, regional shares, competitors with a ablation technology market share, detailed ablation technology market segments, market trends and opportunities, and any further data you may need to thrive in the ablation technology industry. This ablation technology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ablation technology market consists of revenues earned by entities by providing services such as electroporation therapy, endovenous ablation, tumor ablation, and ablation catheter development. The market value includes the value of related goods sold by the service provider or included within the service offering. The ablation technology market also includes sales of high-intensity focused ultrasound systems, ablation catheters, tumor ablation probes, and pain management ablation systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.